Clozapine-induced myocarditis in an adolescent male with DiGeorge Syndrome
Open Access
- 1 November 2018
- journal article
- Published by American Association of Psychiatric Pharmacists (AAPP) in Mental Health Clinician
- Vol. 8 (6) , 313-316
Abstract
DiGeorge Syndrome (22q11.2 deletion syndrome) is a chromosomal disorder associated with both congenital heart malformations and schizophrenia, which is often treatment-resistant and may warrant treatment with clozapine. Clozapine-induced myocarditis (CIM) is a rare complication of clozapine therapy, with a reported incidence ranging from 0.015% to 3%. Fulminant CIM has a nonspecific presentation in both adult and pediatric populations and a mortality rate approaching 50%. Few cases of pediatric CIM have been documented in the literature. This report highlights a case of CIM in an adolescent male with DiGeorge Syndrome whose clinical course was characterized by a subtle, nonspecific presentation and resolution with supportive care.Keywords
This publication has 20 references indexed in Scilit:
- Clozapine use in childhood and adolescent schizophrenia: A nationwide population-based studyEuropean Neuropsychopharmacology, 2015
- Atypical Antipsychotics and Relapsing Psychoses in 22q11.2 Deletion Syndrome: A Long-term Evaluation of 28 PatientsPharmacopsychiatry, 2015
- A systematic review of clozapine induced cardiomyopathyInternational Journal of Cardiology, 2014
- Echocardiographic monitoring for clozapine cardiac toxicity: lessons from real-world experienceAustralasian Psychiatry, 2013
- Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: A case–control studySchizophrenia Research, 2012
- MyocarditisThe Lancet, 2012
- Myocarditis During Clozapine TreatmentAmerican Journal of Psychiatry, 2006
- Clozapine treatment of psychosis associated with velo‐cardio‐facial syndrome: benefits and risksJournal of Intellectual Disability Research, 2005
- Management of Schizophrenia in Children and AdolescentsPediatric Drugs, 2000
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981